MMP-3 or stromelysin-1 (Table 1), which degrades collagen type I, is known to activate MMP-1, MMP-7, and MMP-13 (Table 1), which is associated with MM invasiveness and metastases [3]. This evidence concerns the gene MMP13 and Miyoshi myopathy.